Victoria Soto Martinez, PA
Physician Assistant · Schertz, TXNPI 1225547664
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,424, more than ten times the $136 reported in 2021.
Across 120 payments — averaging $32.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MML US, Inc.$785
- Globus Medical$507
- Sumitomo Pharma America, Inc.$313
- Johnson & Johnson$275
- AbbVie$172
- Astellas Pharma US Inc$169
- plus $2K from 30 others
Across 12 payments — averaging $2555.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bluewind Medical$31K
What the payments were for
- Food & beverage$3,85497%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MML US, Inc. | 14 | $785 |
| Globus Medical | 9 | $507 |
| Sumitomo Pharma America, Inc. | 8 | $313 |
| Johnson & Johnson | 8 | $275 |
| AbbVie(2 entities) | 11 | $172 |
| Astellas Pharma US Inc | 7 | $169 |
| Olympus America Inc. | 1 | $150 |
| Foundation Medicine, Inc. | 3 | $147 |
| Collegium Pharmaceutical, Inc. | 8 | $128 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $124 |
| Procept Biorobotics Corporation | 1 | $113 |
| Si-bone, Inc. | 2 | $101 |
| SPR Therapeutics, Inc | 4 | $89 |
| Pfizer | 5 | $73 |
| Vertos Medical, Inc. | 1 | $70 |
| Abbott | 1 | $68 |
| Tolmar, Inc. | 3 | $68 |
| Halozyme Inc | 3 | $61 |
| Progenics Pharmaceuticals, Inc. | 2 | $61 |
| Boston Scientific | 2 | $60 |
| Nevro Corp. | 2 | $58 |
| Merz Pharmaceuticals, LLC | 3 | $41 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| Vertex | 1 | $35 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Biotronik NRO, Inc. | 1 | $25 |
| Blue Earth Diagnostics | 1 | $25 |
| Novartis | 1 | $22 |
| AstraZeneca | 1 | $20 |
| Urogen Pharma, Inc. | 1 | $20 |
| 180 Medical, Inc. | 1 | $20 |
| Teleflex LLC | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Merck | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ReActiv8$377
- Senza$238
- CYSTO-NEPHRO VIDEOSCOPE$150
- iTIND System$150
- ORGOVYX$135
- Erleada$125
- AquaBeam Robotic System$113
How this compares
$3,954 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 30 | $20,295 |
| GemtesaVibegron | 20 | $19,216 |
| MyrbetriqMirabegron | 19 | $16,048 |
| Buprenorphine | 19 | $4,644 |
| Tramadol Hcl ErTramadol Hcl | 65 | $4,378 |
| Pregabalin | 106 | $3,563 |
| Gabapentin | 123 | $1,907 |
| Lidocaine | 33 | $1,879 |
| Tramadol Hcl | 112 | $715 |
| Tamsulosin Hcl | 70 | $605 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 42 | $550 |
| Dutasteride | 16 | $519 |
| Duloxetine Hcl | 55 | $507 |
| Tizanidine Hcl | 54 | $446 |
| Methocarbamol | 17 | $270 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $128 | $20,29530 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $313 | $19,21620 claims |
| Astellas Pharma US IncMyrbetriq | $169 | $16,04819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Schertz
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
- Heidi JeffreysLubbock$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.